Is liposomal vitamin C worth taking?

Liposomal vitamin C reliably puts more of the vitamin into your bloodstream, and the interesting question is whether that extra ever reaches you as something you would notice.

A 2025 review of ten trials found higher blood exposure in nine of them. The one trial that looked past the bloodstream at a measured effect found the liposomal form did about as well as plain vitamin C, not better.

So the honest answer turns on how much you are trying to take, and where you are starting from.

Table of Contents

• 1. The short answer
• 2. What you are actually buying
• 3. Where plain vitamin C runs out of road
• 4. Does more in the blood mean more for you?
• 5. Who it is probably worth it for
• 6. Who can comfortably skip it
• 7. What is still unknown
• Bio Absorb Liposomal Vitamin C
• Frequently Asked Questions
• Conclusion
• Research References

1. The short answer

For most healthy adults aiming at an ordinary daily dose, liposomal vitamin C is not worth taking. Plain ascorbic acid already reaches the levels your body can use, and the research has not shown the liposomal form producing anything extra once it gets there.

It becomes worth considering in three situations: when you are aiming at a dose high enough that ordinary absorption becomes the limiting factor, when plain vitamin C upsets your stomach, or when you are starting from a genuinely low vitamin C status. Those are real cases, and for the people in them the format does something that plain powder or tablets cannot.

That is a narrower answer than most pages give, and it comes from two findings that sit side by side and are usually quoted one at a time. The rest of this article is those two findings and what follows from holding both.

2. What you are actually buying

You are buying higher blood levels from the same milligram count. That part is settled. A 2025 scoping review in Basic & Clinical Pharmacology & Toxicology pulled together every study that had compared the two forms head to head and found nine of ten reported higher plasma bioavailability for the liposomal version.

The size of that advantage varies enormously. Across the studies that showed one, blood exposure over time ran 1.3 to 7.2 times higher and peak concentration 1.2 to 5.4 times higher. The review attributes the spread to differences in how each liposomal product was made, the dose used, how long researchers kept sampling, and the vitamin C status participants started with. That last one matters more than it sounds, and it comes back in section 5.

Smaller, tighter studies land near the bottom of that range rather than the top. A 2024 randomised crossover trial in the European Journal of Nutrition gave 27 adults a single 500 mg dose and measured a 21% increase in blood exposure. Useful, but a long way from seven times. Treat any single advertised multiple with suspicion; the range is the honest figure, and our guide to vitamin C absorption explains why it is so wide.

3. Where plain vitamin C runs out of road

Vitamin C is absorbed by a transport system that works efficiently at small doses and then stops keeping up. The classic pharmacokinetic work, published in PNAS in 1996, mapped where that happens: white blood cells reached saturation at about 100 mg a day, and plasma at about 1,000 mg a day.

Above those points, extra intake mostly leaves in your urine. The National Institutes of Health puts the practical consequence plainly: at intakes above 1 g a day, absorption falls below 50%. The recommended intake sits far below that, at 90 mg a day for men and 75 mg for women, with an extra 35 mg a day for smokers.

Read those two paragraphs together and the shape of the answer appears. If you are taking 200 mg a day, you are nowhere near the ceiling, and a delivery system designed to get you past the ceiling has nothing to do. If you are taking 2,000 mg a day, you are losing more than half of it, and the format is suddenly doing real work. The question is not whether liposomal delivery works. It is whether your dose is high enough for it to matter.

4. Does more in the blood mean more for you?

This is the part that decides the question, and the evidence is thinner than the absorption data by a wide margin.

Almost every liposomal vitamin C trial stops at the blood test. One did not. A randomised, placebo-controlled crossover study published in Nutrition and Metabolic Insights in 2016 gave eleven adults 4 g of vitamin C as plain oral, liposomal oral, or intravenous, then measured a marker of oxidative stress after a forearm ischemia–reperfusion test. The liposomal form produced higher circulating vitamin C than plain oral, as expected. The protective effect, though, came out similar across all three routes, including intravenous.

One small trial with one outcome measure does not settle anything, and it should not be read as proof that the format does nothing. The authors noted the dose needed for that particular protection is probably below 4 g, which may simply mean everyone in the study had enough. But it is the only direct look we have past the bloodstream, and it did not find the advantage the blood levels would predict. The absorption benefit is established. The benefit you would feel is, for now, an assumption rather than a finding.

5. Who it is probably worth it for

Three groups have a sensible case, and they are narrower than the marketing suggests.

People targeting high doses. If you and your doctor have settled on an intake near the 2,000 mg daily upper limit, ordinary absorption is the bottleneck, and a format that widens it is doing something measurable rather than theoretical.

People whose stomachs object. The familiar complaints at higher doses, loose stools and cramping, come from unabsorbed ascorbic acid drawing water into the gut. Anything that gets more of the dose absorbed before it reaches that point tends to be easier to tolerate, which is why people who gave up on high-dose vitamin C often get on better with a liposomal or buffered form.

People starting from a low baseline. The 2025 review named baseline vitamin C status as one reason the absorption advantage varies so much between studies. Someone replete has less room to gain than someone depleted, which is a reasonable argument for people with poor diets, high requirements, or repeated demands on their vitamin C stores.

6. Who can comfortably skip it

If your target is somewhere around 100 to 400 mg a day, which covers most people topping up a reasonable diet, plain vitamin C is doing the job. You are below the saturation points mapped in 1996, absorption at that range is efficient, and there is no ceiling for the liposomal format to lift you over.

The same goes for anyone buying vitamin C mainly for colds. The Cochrane review of 31 comparisons found that regular supplementation of at least 200 mg a day shortened colds by about 8% in adults, and no consistent benefit when people started taking it after symptoms appeared. That modest effect was found with ordinary vitamin C at a dose well inside the efficient range. No trial has tested whether the liposomal form improves on it.

And if you tolerate ascorbic acid without trouble and your diet is decent, the main thing the liposomal format offers you is a higher number on a blood test nobody is going to run.

7. What is still unknown

The honest state of the evidence is early. The UK Committee on Toxicity reviewed this class of supplement in 2025 and found only a handful of controlled human studies of liposomal vitamin C, with five in its summary table. It also raised a point most product pages skip: safety limits were set for ordinary supplements, and whether they still fit forms designed to absorb better deserves consideration rather than assumption.

A 2025 systematic review in Nutrients reached a similar place, describing research on liposomal forms as still at early stages. Nearly all the trials used single doses, measured for a few hours, in small groups. Several were funded by companies selling the product being tested, which is normal in supplement research and still worth knowing.

Three things would change this answer: longer trials, outcomes measured beyond plasma, and head-to-head data in people who are actually deficient. None of those exists yet in any quantity.

Bio Absorb Liposomal Vitamin C — Two Formats, One Standard

Bio Absorb Nutraceuticals makes liposomal vitamin C in two formats, and the choice between them is mostly about which routine you will actually keep.

The Liposomal Vitamin C Liquid 1000mg (Corn-Free) mixes with water or juice and lets you measure your own amount, which suits anyone splitting an intake across the day. The Liposomal Vitamin C Capsules 1000mg (Corn-Free) have no taste, need no refrigeration and travel well.

Both use liposomal delivery, with vitamin C held inside phospholipids. Both are verified corn-free, non-GMO, gluten-free, nut-free and vegan, made in a GMP-certified facility in Canada and third-party tested every batch, and both carry a money-back guarantee. The corn-free sourcing is worth a mention here because most ascorbic acid on the market is fermented from corn, which matters if you react to it.

What we are not going to tell you is that our version clears the evidence gap in section 4. It does not. The absorption case for liposomal delivery is strong and the outcome case is unproven, and that is as true of ours as of anyone's. For serving details and current pricing, see the liquid product page or the capsule product page, and take either to your pharmacist if you are on medication.

Frequently Asked Questions

Is liposomal vitamin C better than regular vitamin C?

Better absorbed, yes. The 2025 scoping review found higher blood exposure in nine of ten trials. Whether that makes it better for you is a separate question, and the one trial that tested a measured outcome found no advantage. Our comparison of liposomal vitamin C goes through the evidence in full.

Is liposomal vitamin C worth it for colds?

There is no trial testing that. The Cochrane evidence for vitamin C and colds comes from ordinary forms at doses around 200 mg a day, well inside the range plain vitamin C absorbs efficiently, so the liposomal format has no gap to close there.

Can I take less liposomal vitamin C because it absorbs better?

Not by any fixed amount. The 1.3 to 7.2 times range describes blood exposure over time, which partly reflects how long vitamin C stays in circulation, so it does not convert into an equivalent dose. Plan your amount as you would for plain vitamin C.

Does liposomal vitamin C count toward the 2,000 mg upper limit?

Yes. The 2,000 mg limit covers food and supplements together, in any form. The UK Committee on Toxicity goes further and questions whether limits written for ordinary supplements fit forms built for higher absorption, so count everything.

Who should check with a doctor first?

Anyone with a history of kidney stones or kidney disease, anyone with haemochromatosis, and anyone taking regular medication. Vitamin C has documented interactions with several medicines, and better absorption is a reason to be more careful about that, not less.

Is liposomal vitamin C a waste of money?

Not inherently, but it is easy to buy for the wrong reason. If you are taking a modest daily amount and tolerating it fine, you are paying for an advantage you have no use for. If you are pushing toward the upper limit or struggling with stomach upset, you are buying something real.

Conclusion

So, is liposomal vitamin C worth taking? It is worth taking if your dose is high enough that ordinary absorption has stopped keeping up, if plain ascorbic acid troubles your stomach, or if you are starting from a low baseline — and it is a reasonable thing to skip if none of those is you. The 1.3 to 7.2 times absorption advantage is real; what it buys you downstream is still being worked out. If the format fits your situation, see current pricing and serving details for Bio Absorb Liposomal Vitamin C before deciding on an amount.

Research References

1. Do Liposomal Vitamin C Formulations Have Improved Bioavailability? A Scoping Review Identifying Future Research Directions. Basic & Clinical Pharmacology & Toxicology, Vol. 137, Issue 1, e70067 (2025). Ten studies reviewed; nine reported higher plasma bioavailability for liposomal vitamin C, with AUC 1.3 to 7.2 times higher and Cmax 1.2 to 5.4 times higher.
2. Liposomal-encapsulated Ascorbic Acid: Influence on Vitamin C Bioavailability and Capacity to Protect Against Ischemia–Reperfusion Injury. Nutrition and Metabolic Insights, Vol. 9, pp. 25–30 (2016). Eleven adults given 4 g doses; liposomal produced higher circulating vitamin C than plain oral but similar protection against oxidative stress.
3. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences of the USA, Vol. 93 (1996). White blood cells saturated at about 100 mg a day and plasma at about 1,000 mg a day.
4. Liposomal delivery enhances absorption of vitamin C into plasma and leukocytes: a double-blind, placebo-controlled, randomized trial. European Journal of Nutrition, Vol. 63, Issue 8, pp. 3037–3046 (2024). A single 500 mg liposomal dose raised blood exposure by 21% in 27 adults.
5. Vitamin C: Fact Sheet for Health Professionals. National Institutes of Health, Office of Dietary Supplements (2025). Source for the adult RDAs, the extra 35 mg a day for smokers, the sub-50% absorption figure above 1 g a day, and the 2,000 mg Tolerable Upper Intake Level.
6. Novel formulations of supplement compounds designed to increase oral bioavailability. UK Committee on Toxicity (2025). Found only a handful of controlled human studies of liposomal vitamin C and recommends considering whether standard safety limits fit high-bioavailability formulations.
7. Enhanced Vitamin C Delivery: A Systematic Literature Review Assessing the Efficacy and Safety of Alternative Supplement Forms in Healthy Adults. Nutrients, Vol. 17, Issue 2, Article 279 (2025). Describes research on liposomal vitamin C as still at early stages.
8. Vitamin C for preventing and treating the common cold. Cochrane Database of Systematic Reviews, CD000980 (2013). Regular intake of at least 200 mg a day shortened colds by 8% in adults; no consistent effect when started after symptoms began.
9. Vitamin C. National Health Service, United Kingdom. General reference for adult requirements and supplement safety guidance.

About the Author

David Kimbell is a health writer, digital entrepreneur and former aerospace engineer, based in Ottawa, Canada. He loves translating complex science into clear, actionable guidance for consumers seeking evidence-based solutions.

---

Important Disclaimers

Medical Disclaimer: This article provides educational information only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have existing health conditions, take medications, or are pregnant or nursing.

FDA/Health Canada Statement: These statements have not been evaluated by the Food and Drug Administration or Health Canada. This product is not intended to diagnose, treat, cure, or prevent any disease.